Clinical Trials · NCT07195994
A Clinical Trial to Examine the Efficacy and Safety of an Investigational Product With and Without Use of Semaglutide on Glycemic Response in Adults With Prediabetes or Type 2 Diabetes
- Phase
- N/A
- Recruitment status
- Recruiting
- Sponsor
- QuickSilver Scientific
- Enrollment
- 90
- Start date
- Feb 2026
- Locations
- 1 site, Canada
- Primary endpoint
- The difference in change in fasting blood glucose between AMPK Charge+® and AMPK Charge+® with semaglutide